IL6 and endometrial cancer: Che et al. [47] reported that addition IL-6 antibody to a co-culture of estradiol and endometrial cancer cells abrogated the estradiol-induced increased endometrial cancer cell cycle promoter cyclin D1 which leads to the conclusion that IL-6 is necessary for the estradiol-induced endometrial cancer cell cycle progression.